Yuhua Wang

Yuhua (Albert) Wang is an accomplished professional in the biopharmaceutical field, currently serving as Associate Director at CRISPR Therapeutics since March 2022, where leadership of the non-viral delivery team focuses on the development and manufacturing of lipid nanoparticles, messenger RNA, and guide RNA for gene editing. Prior experience includes roles as Principal Scientist and Healthcare Consultant at Cobbs Creek Healthcare, and Director of Research at OncoTrap Inc., where Yuhua built a startup and developed novel antibody discovery systems, additionally securing an NIH SBIR grant. Educational qualifications include a Postgraduate Degree in Pharmaceutical Sciences from the University of North Carolina at Chapel Hill, a PhD in Pharmaceutical Sciences from Washington State University, and a Bachelor's degree in Life Sciences from Fudan University.